GMT — Genomtec SA Cashflow Statement
0.000.00%
- PLN111.50m
- PLN107.96m
- PLN0.00m
Annual cashflow statement for Genomtec SA, fiscal year end - December 31st, PLN millions except per share, conversion factor applied.
2019 December 31st | R2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | PRESS | ARS | ARS |
Standards: | PAS | IFRS | — | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -1.45 | -10.9 | -5.27 | -11.9 | -9.01 |
Depreciation | |||||
Non-Cash Items | -1.22 | 9.04 | -0.038 | 4.84 | 0.011 |
Other Non-Cash Items | |||||
Changes in Working Capital | 0.858 | -0.852 | -0.492 | 3.05 | -0.106 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Taxes Payable | |||||
Change in Other Liabilities | |||||
Net Change in Other Assets & Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | -1.69 | -2.5 | -5.48 | -3.6 | -7.95 |
Capital Expenditures | -0.491 | -0.127 | -0.218 | -4.33 | -3.53 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | -0.018 | 0.051 | 0 | — | -0.277 |
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -0.509 | -0.076 | -0.218 | -4.33 | -3.8 |
Financing Cash Flow Items | 1.21 | -0.018 | -0.022 | -0.191 | -0.1 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 3.28 | 8.45 | -0.218 | 10.7 | 11.8 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 1.08 | 5.87 | -5.92 | 2.77 | 0.042 |